| Year |
Citation |
Score |
| 2023 |
Gor R, Gharib A, Dharshini Balaji P, Madhavan T, Ramalingam S. Inducing Cytotoxicity in Colon Cancer Cells and Suppressing Cancer Stem Cells by Dolasetron and Ketoprofen through Inhibition of RNA Binding Protein PUM1. Toxics. 11. PMID 37624174 DOI: 10.3390/toxics11080669 |
0.468 |
|
| 2023 |
Andrabi MQ, Kesavan Y, Ramalingam S. Non-Coding RNA as Biomarkers for Survival in Colorectal Cancer Patients. Current Aging Science. PMID 36733201 DOI: 10.2174/1874609816666230202101054 |
0.315 |
|
| 2023 |
Gor R, Ramachandran I, Ramalingam S. Targeting the Cancer Stem Cells in Endocrine Cancers with Phytochemicals. Current Topics in Medicinal Chemistry. 22: 2589-2597. PMID 36380414 DOI: 10.2174/1567205020666221114112814 |
0.416 |
|
| 2022 |
Gor R, Saha L, Agarwal S, Karri U, Sohani A, Madhavan T, Pachaiappan R, Ramalingam S. Morin inhibits colon cancer stem cells by inhibiting PUM1 expression in vitro. Medical Oncology (Northwood, London, England). 39: 251. PMID 36224472 DOI: 10.1007/s12032-022-01851-4 |
0.449 |
|
| 2022 |
Lazer LM, Kesavan Y, Gor R, Ramachandran I, Pathak S, Narayan S, Anbalagan M, Ramalingam S. Targeting colon cancer stem cells using novel doublecortin like kinase 1 antibody functionalized folic acid conjugated hesperetin encapsulated chitosan nanoparticles. Colloids and Surfaces. B, Biointerfaces. 217: 112612. PMID 35738074 DOI: 10.1016/j.colsurfb.2022.112612 |
0.372 |
|
| 2021 |
Solairaja S, Ramalingam S, Dunna NR, Venkatabalasubramanian S. Progesterone Receptor Membrane Component 1 and Its Accomplice: Emerging Therapeutic Targets in Lung Cancer. Endocrine, Metabolic & Immune Disorders Drug Targets. PMID 34847852 DOI: 10.2174/1871530321666211130145542 |
0.304 |
|
| 2021 |
Vijai M, Baba M, Ramalingam S, Thiyagaraj A. DCLK1 and its interaction partners: An effective therapeutic target for colorectal cancer. Oncology Letters. 22: 850. PMID 34733368 DOI: 10.3892/ol.2021.13111 |
0.381 |
|
| 2021 |
Subramaniam D, Ponnurangam S, Ramalingam S, Kwatra D, Dandawate P, Weir SJ, Umar S, Jensen RA, Anant S. Honokiol Affects Stem Cell Viability by Suppressing Oncogenic YAP1 Function to Inhibit Colon Tumorigenesis. Cells. 10. PMID 34206989 DOI: 10.3390/cells10071607 |
0.419 |
|
| 2021 |
Panicker S, Venkatabalasubramanian S, Pathak S, Ramalingam S. The impact of fusion genes on cancer stem cells and drug resistance. Molecular and Cellular Biochemistry. PMID 34095988 DOI: 10.1007/s11010-021-04203-4 |
0.301 |
|
| 2021 |
Gor R, Sampath SS, Lazer LM, Ramalingam S. RNA binding protein PUM1 promotes colon cancer cell proliferation and migration. International Journal of Biological Macromolecules. PMID 33508364 DOI: 10.1016/j.ijbiomac.2021.01.154 |
0.471 |
|
| 2020 |
Muthusami S, Ramachandran I, Krishnamoorthy S, Sambandam Y, Ramalingam S, Queimado L, Chaudhuri G, Kumaran RI. Regulation of microRNAs in Inflammation-Associated Colorectal Cancer: A Mechanistic Approach. Endocrine, Metabolic & Immune Disorders Drug Targets. PMID 32940190 DOI: 10.2174/1871530320666200917112802 |
0.336 |
|
| 2020 |
Sampath SS, Venkatabalsubramanian S, Ramalingam S. Role of MicroRNAs in Colon Cancer Progression and Metastasis. Endocrine, Metabolic & Immune Disorders Drug Targets. PMID 32842949 DOI: 10.2174/1871530320666200825184924 |
0.339 |
|
| 2019 |
Roy BC, Ahmed I, Ramalingam S, Jala V, Haribabu B, Ramamoorthy P, Ashcraft J, Valentino J, Anant S, Sampath V, Umar S. Co-localization of autophagy-related protein p62 with cancer stem cell marker dclk1 may hamper dclk1's elimination during colon cancer development and progression. Oncotarget. 10: 2340-2354. PMID 31040926 DOI: 10.18632/Oncotarget.26684 |
0.42 |
|
| 2019 |
New J, Subramaniam D, Ramalingam S, Enders J, Sayed AAA, Ponnurangam S, Standing D, Ramamoorthy P, O'Neil M, Dixon DA, Saha S, Umar S, Gunewardena S, Jensen RA, Thomas SM, et al. Pleotropic role of RNA binding protein CELF2 in autophagy induction. Molecular Carcinogenesis. PMID 31020708 DOI: 10.1002/Mc.23023 |
0.455 |
|
| 2019 |
Ramamoorthy P, Thomas SM, Kaushik G, Subramaniam D, Chastain KM, Dhar A, Tawfik O, Kasi A, Sun W, Ramalingam S, Gunewardena S, Umar S, Mammen JMV, Padhye SB, Weir SJ, et al. Metastatic Tumor-In-A-Dish, A Novel Multi-Cellular Organoid to Study Lung Colonization and Predict Therapeutic Response. Cancer Research. PMID 30674533 DOI: 10.1158/0008-5472.Can-18-2602 |
0.419 |
|
| 2018 |
Paramita P, Subramaniam VD, Murugesan R, Gopinath M, Ramachandran I, Ramalingam S, Sun XF, Banerjee A, Marotta F, Pathak S. Evaluation of potential anti-cancer activity of cationic liposomal nanoformulated in colon cancer cells. Iet Nanobiotechnology. 12: 727-732. PMID 30104445 DOI: 10.1049/Iet-Nbt.2017.0106 |
0.492 |
|
| 2017 |
Mary L, Sadhasivam B, Palaniyandi K, Muthuswamy T, Ramachandran I, Balakrishnan A, Pathak S, Narayan S, Ramalingam S. Chitosan-Based Nano-Formulation Enhanced the Anticancer Efficacy of Hesperetin. International Journal of Biological Macromolecules. PMID 29032208 DOI: 10.1016/J.Ijbiomac.2017.10.064 |
0.483 |
|
| 2016 |
Palaniappan A, Ramar K, Ramalingam S. Computational Identification of Novel Stage-Specific Biomarkers in Colorectal Cancer Progression. Plos One. 11: e0156665. PMID 27243824 DOI: 10.1371/Journal.Pone.0156665 |
0.66 |
|
| 2015 |
Rangarajan P, Subramaniam D, Paul S, Kwatra D, Palaniyandi K, Islam S, Harihar S, Ramalingam S, Gutheil W, Putty S, Pradhan R, Padhye S, Welch DR, Anant S, Dhar A. Crocetinic acid inhibits hedgehog signaling to inhibit pancreatic cancer stem cells. Oncotarget. 6: 27661-73. PMID 26317547 DOI: 10.18632/Oncotarget.4871 |
0.459 |
|
| 2015 |
Ramalingam S, Subramaniam D, Anant S. Manipulating miRNA Expression: A Novel Approach for Colon Cancer Prevention and Chemotherapy. Current Pharmacology Reports. 1: 141-153. PMID 26029495 DOI: 10.1007/S40495-015-0020-3 |
0.426 |
|
| 2015 |
Sainathan SK, Paul S, Palaniyandi K, Subramaniam D, Ramalingam S, Tawfik OW, Iwakuma T, Welch DR, Padhye SB, Anant S, Dhar A. Abstract 2338: Histone demethylase KDM3A: Epigenetic target for pancreatic ductal adenocarcinoma (PDAC) Cancer Research. 75: 2338-2338. DOI: 10.1158/1538-7445.Am2015-2338 |
0.535 |
|
| 2015 |
Rangarajan P, Ramalingam S, Subramaniam D, Baltezor MJ, Wood R, Anant S, Weir S. Abstract 1895: Ciclopirox prodrug for the prevention and therapy of non-muscle invasive bladder cancer Cancer Research. 75: 1895-1895. DOI: 10.1158/1538-7445.Am2015-1895 |
0.502 |
|
| 2015 |
Subramaniam D, Ponnurangam S, Kwatra D, Kaushik G, Ramamoorthy P, Ramalingam S, Tawfik O, Weir SJ, Padhye S, Dixon DA, Umar S, Jensen RA, Anant S. Abstract 1893: Honokiol prevents colonic tumorigenesis and affects stem cell viability by affecting oncogenic YAP1 function Cancer Research. 75: 1893-1893. DOI: 10.1158/1538-7445.Am2015-1893 |
0.512 |
|
| 2015 |
Ramamoorthy P, Ramalingam S, Subramaniam D, Dandawate P, Tawfik O, Jensen RA, Baranda JC, Weir SJ, Olyaee MS, Padhye S, Sittampalam GS, Anant S. 293 A Novel “Tumor in a Dish” Method to Study Primary and Metastatic Colon Cancer; Differential Therapeutic Responses in Cancers With Mismatch Repair Defects Gastroenterology. 148. DOI: 10.1016/S0016-5085(15)30222-5 |
0.449 |
|
| 2015 |
Sainathan S, Paul S, Ramalingam S, Baranda J, Anant S, Dhar A. Histone Demethylases in Cancer Current Pharmacology Reports. 1: 234-244. DOI: 10.1007/S40495-015-0025-Y |
0.344 |
|
| 2014 |
Paul S, Ramalingam S, Subramaniam D, Baranda J, Anant S, Dhar A. Histone Demethylases in Colon Cancer. Current Colorectal Cancer Reports. 10: 417-424. PMID 25574158 DOI: 10.1007/S11888-014-0253-2 |
0.458 |
|
| 2014 |
Palaniyandi K, Paul S, Rangarajan P, Kwatra D, Ramalingam S, Subramaniam D, Iwakuma T, Padhye S, Anant S, Dhar A. Abstract 5163: JMJD1a: A potential target for prevention and therapy in pancreatic cancer Cancer Research. 74: 5163-5163. DOI: 10.1158/1538-7445.Am2014-5163 |
0.534 |
|
| 2013 |
Ramamoorthy P, Byrne S, Ramalingam S, Rangarajan P, Subramaniam D, Weir S, Anant S, Jensen R. Abstract PR05: Effects of Hsp90 inhibitors on triple-negative breast cancer: Notch as a therapeutic target for stem cells Cancer Prevention Research. 6. DOI: 10.1158/1940-6215.Prev-13-Pr05 |
0.496 |
|
| 2013 |
Palaniyandi K, Islam S, Rangarajan P, Kwatra D, Ramalingam S, Subramaniam D, Padhye S, Anant S, Dhar A. Abstract C40: Histone demethylase Jmjd1a: A novel preventive target in pancreatic cancer Cancer Prevention Research. 6. DOI: 10.1158/1940-6215.Prev-13-C40 |
0.534 |
|
| 2013 |
Rangarajan P, Ramamoorthy P, Ramalingam S, Subramaniam D, Ponnurangam S, Weir S, Anant S, Jensen R. Abstract B32: Gedunin induces autophagy during mitosis, a novel form of mitotic catastrophe Cancer Prevention Research. 6. DOI: 10.1158/1940-6215.Prev-13-B32 |
0.499 |
|
| 2013 |
Ramalingam S, Subramaniam d, Anant S. Abstract 3901: RBM3 drives tumor angiogenesis by modulating miR-210. Cancer Research. 73: 3901-3901. DOI: 10.1158/1538-7445.Am2013-3901 |
0.453 |
|
| 2013 |
Subramaniam D, Ponnurangam S, Umar S, Ramalingam S, Jensen RA, Anant S. Abstract 3662: Honokiol affects stem cell viability in part through suppression of Hippo signaling pathway. Cancer Research. 73: 3662-3662. DOI: 10.1158/1538-7445.Am2013-3662 |
0.525 |
|
| 2013 |
Venugopal A, Kwatra D, Ponnurangam S, Subramaniam D, Ramalingam S, Umar S, Anant S. Tu1597 RNA Binding Protein RBM3 Enhances Stem Cell Characteristics and Wnt/β-Catenin Signaling in Colorectal Cancer Gastroenterology. 144. DOI: 10.1016/S0016-5085(13)62966-2 |
0.423 |
|
| 2012 |
Ramalingam S, Ramamoorthy P, Subramaniam D, Anant S. Reduced Expression of RNA Binding Protein CELF2, a Putative Tumor Suppressor Gene in Colon Cancer. Immuno-Gastroenterology. 1: 27-33. PMID 23795348 DOI: 10.7178/ig.1.1.7 |
0.444 |
|
| 2012 |
Kaushik G, Ramalingam S, Subramaniam D, Rangarajan P, Protti P, Rammamoorthy P, Anant S, Mammen JM. Honokiol induces cytotoxic and cytostatic effects in malignant melanoma cancer cells. American Journal of Surgery. 204: 868-73. PMID 23231930 DOI: 10.1016/J.Amjsurg.2012.09.001 |
0.392 |
|
| 2012 |
Moriasi C, Subramaniam D, Awasthi S, Ramalingam S, Anant S. Prevention of colitis-associated cancer: natural compounds that target the IL-6 soluble receptor. Anti-Cancer Agents in Medicinal Chemistry. 12: 1221-38. PMID 22583410 DOI: 10.2174/187152012803833080 |
0.368 |
|
| 2012 |
Ponnurangam S, Mammen JM, Ramalingam S, He Z, Zhang Y, Umar S, Subramaniam D, Anant S. Honokiol in combination with radiation targets notch signaling to inhibit colon cancer stem cells. Molecular Cancer Therapeutics. 11: 963-72. PMID 22319203 DOI: 10.1158/1535-7163.Mct-11-0999 |
0.54 |
|
| 2012 |
Ramachandran I, Thavathiru E, Ramalingam S, Natarajan G, Mills WK, Benbrook DM, Zuna R, Lightfoot S, Reis A, Anant S, Queimado L. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo Oncogene. 31: 2725-2737. PMID 22002305 DOI: 10.1038/Onc.2011.455 |
0.503 |
|
| 2012 |
Ramalingam S, Subramaniam D, Standing D, Neradugomma NK, Umar S, Anant S. Abstract 5287: RNA binding protein RBM3 promotes metastasis through induction of hemangiogenesis and lymphangiogenesis Cancer Research. 72: 5287-5287. DOI: 10.1158/1538-7445.Am2012-5287 |
0.434 |
|
| 2012 |
Somasundaram RT, Ramalingam S, Subramaniam D, Sethi G, Weir J, Nirmalanandhan VS, Godwin AK, Shrikant A, Sittampalam GS. Abstract 433: Expression of stem cell and EMT markers on circulating tumor cells Cancer Research. 72: 433-433. DOI: 10.1158/1538-7445.Am2012-433 |
0.502 |
|
| 2012 |
Subramaniam D, Ponnurangam S, Ramalingam S, He Z, Zhang Y, Anant S. Abstract 1007: Honokiol inhibits colon cancer stem cell growth and mechanism mediated through Notch signaling pathway Cancer Research. 72: 1007-1007. DOI: 10.1158/1538-7445.Am2012-1007 |
0.537 |
|
| 2011 |
He Z, Subramaniam D, Ramalingam S, Dhar A, Postier RG, Umar S, Zhang Y, Anant S. Honokiol radiosensitizes colorectal cancer cells: enhanced activity in cells with mismatch repair defects. American Journal of Physiology. Gastrointestinal and Liver Physiology. 301: G929-37. PMID 21836060 DOI: 10.1152/Ajpgi.00159.2011 |
0.432 |
|
| 2011 |
Subramaniam D, Ramalingam S, Linehan DC, Dieckgraefe BK, Postier RG, Houchen CW, Jensen RA, Anant S. RNA binding protein CUGBP2/CELF2 mediates curcumin-induced mitotic catastrophe of pancreatic cancer cells. Plos One. 6: e16958. PMID 21347286 DOI: 10.1371/Journal.Pone.0016958 |
0.469 |
|
| 2011 |
Ramachandran I, Reis AMC, Anant S, Queimado L, Thavathiru E, Ramalingam S, Natarajan G, Mills WK, Benbrook D, Zuna R, Lightfoot S. Abstract C21: Wnt inhibitory factor 1 is silenced by promoter hypermethylation in cervical cancer and its restoration suppresses tumor growth Cancer Research. 71. DOI: 10.1158/1538-7445.Fbcr11-C21 |
0.497 |
|
| 2011 |
Moriasi CM, Trevino C, Subramaniam D, Ramalingam S, Awasthi V, Awasthi S, Anant S. Abstract 4606: Curcumin regulates Interleukin-6 expression in colon cancer cells Cancer Research. 71: 4606-4606. DOI: 10.1158/1538-7445.Am2011-4606 |
0.343 |
|
| 2011 |
Ramalingam S, Subramaniam D, Jensen RA, Anant S. Abstract 4362: RBM3 overexpression promotes cancer stem cell expansion through activation of Notch-1 signaling Cancer Research. 71: 4362-4362. DOI: 10.1158/1538-7445.Am2011-4362 |
0.49 |
|
| 2011 |
Venugopal A, Ramalingam S, Subramaniam D, He Z, Jensen R, Anant S. Abstract 3080: Novel splicing activity for RNA binding protein CUGBP2 in radiation-induced mitotic catastrophe Cancer Research. 71: 3080-3080. DOI: 10.1158/1538-7445.Am2011-3080 |
0.439 |
|
| 2011 |
Ramalingam S, Subramaniam D, He Z, Houchen CW, Anant S. Radiation Induces Autophagic Cell Death of Colon Cancer Cells in Part Through Increasing RNA Binding Protein CUGBP2 Expression Gastroenterology. 140: S-828. DOI: 10.1016/S0016-5085(11)63431-8 |
0.477 |
|
| 2010 |
Anant S, Houchen CW, Pawar V, Ramalingam S. Role of RNA-Binding Proteins in Colorectal Carcinogenesis. Current Colorectal Cancer Reports. 6: 68-73. PMID 20401169 DOI: 10.1007/S11888-010-0048-Z |
0.383 |
|
| 2010 |
Subramaniam D, Ramalingam S, Houchen CW, Anant S. Cancer stem cells: a novel paradigm for cancer prevention and treatment. Mini Reviews in Medicinal Chemistry. 10: 359-71. PMID 20370703 DOI: 10.2174/138955710791330954 |
0.522 |
|
| 2010 |
Ramachandran I, Ramalingam S, Natarajan G, Mills WK, Anant S, Reis AMC, Queimado L. Abstract 3055: Wnt inhibitory factor 1 inhibits cervical cancer cell growthin vitro Cancer Research. 70: 3055-3055. DOI: 10.1158/1538-7445.Am10-3055 |
0.455 |
|
| 2010 |
Ramalingam S, Subramaniam D, Natarajan G, Ramachandran I, May R, Queimado L, Lightfoot SA, Houchen CW, Anant S. Abstract 2347: Inhibition of metastasis: A novel role for RNA binding protein CUGBP2 Cancer Research. 70: 2347-2347. DOI: 10.1158/1538-7445.Am10-2347 |
0.502 |
|
| 2010 |
Moriasi CM, Ramalingam S, Subramaniam D, He Z, May R, Lightfoot SA, Ihnat MA, Ramanujam RP, Houchen CW, Anant S. Abstract 1890: Curcumin inhibits tumor angiogenesis by suppressing protooncogene RBM3 expression Cancer Research. 70: 1890-1890. DOI: 10.1158/1538-7445.Am10-1890 |
0.34 |
|
| 2009 |
Sureban SM, May R, Ramalingam S, Subramaniam D, Natarajan G, Anant S, Houchen CW. Selective blockade of DCAMKL-1 results in tumor growth arrest by a Let-7a MicroRNA-dependent mechanism. Gastroenterology. 137: 649-59, 659.e1-2. PMID 19445940 DOI: 10.1053/J.Gastro.2009.05.004 |
0.366 |
|
| 2009 |
Ramalingam S, Subramaniam D, May R, Houchen CW, Anant S. W1949 CUGBP2 Overexpression Induces Autophagy in Colon Cancer Cells When Radiation-Induced Mitotic Catastrophe Is Inhibited Gastroenterology. 136. DOI: 10.1016/S0016-5085(09)63507-1 |
0.462 |
|
| 2009 |
Ramalingam S, Natarajan G, May R, Lightfoot SA, Awasthi V, Houchen CW, Anant S. S1997 Overexpression of Proto-Oncogene RBM3 Induces Potent Tumor Formation By Converting Normal Cells to Cancer Stem Cells Gastroenterology. 136: A-309-A-310. DOI: 10.1016/S0016-5085(09)61413-X |
0.488 |
|
| 2008 |
Sureban SM, May R, George RJ, Dieckgraefe BK, McLeod HL, Ramalingam S, Bishnupuri KS, Natarajan G, Anant S, Houchen CW. Knockdown of RNA binding protein musashi-1 leads to tumor regression in vivo. Gastroenterology. 134: 1448-58. PMID 18471519 DOI: 10.1053/J.Gastro.2008.02.057 |
0.393 |
|
| 2008 |
Sureban SM, Ramalingam S, Natarajan G, May R, Subramaniam D, Bishnupuri KS, Morrison AR, Dieckgraefe BK, Brackett DJ, Postier RG, Houchen CW, Anant S. Translation regulatory factor RBM3 is a proto-oncogene that prevents mitotic catastrophe. Oncogene. 27: 4544-56. PMID 18427544 DOI: 10.1038/Onc.2008.97 |
0.472 |
|
| 2008 |
Subramaniam D, Ramalingam S, May R, Dieckgraefe BK, Berg DE, Pothoulakis C, Houchen CW, Wang TC, Anant S. Gastrin-mediated interleukin-8 and cyclooxygenase-2 gene expression: differential transcriptional and posttranscriptional mechanisms. Gastroenterology. 134: 1070-82. PMID 18395088 DOI: 10.1053/J.Gastro.2008.01.040 |
0.344 |
|
| 2008 |
Natarajan G, Ramalingam S, Ramachandran I, May R, Queimado L, Houchen CW, Anant S. CUGBP2 downregulation by prostaglandin E2 protects colon cancer cells from radiation-induced mitotic catastrophe. American Journal of Physiology. Gastrointestinal and Liver Physiology. 294: G1235-44. PMID 18325984 DOI: 10.1152/Ajpgi.00037.2008 |
0.452 |
|
| 2008 |
Subramaniam D, Natarajan G, Ramalingam S, Ramachandran I, May R, Queimado L, Houchen CW, Anant S. Translation inhibition during cell cycle arrest and apoptosis: Mcl-1 is a novel target for RNA binding protein CUGBP2. American Journal of Physiology. Gastrointestinal and Liver Physiology. 294: G1025-32. PMID 18292181 DOI: 10.1152/Ajpgi.00602.2007 |
0.434 |
|
| 2008 |
Ramalingam S, Natarajan G, Schafer C, Subramaniam D, May R, Ramachandran I, Queimado L, Houchen CW, Anant S. Novel intestinal splice variants of RNA-binding protein CUGBP2: isoform-specific effects on mitotic catastrophe. American Journal of Physiology. Gastrointestinal and Liver Physiology. 294: G971-81. PMID 18258790 DOI: 10.1152/Ajpgi.00540.2007 |
0.378 |
|
| 2008 |
Natarajan G, Ramalingam S, Ramachandran I, May R, Queimado L, Houchen CW, Anant S. S1652 Inhibition of CUGBP2 By Prostaglandin E2 Suppresses Radiation-Mediated Mitotic Catastrophe in Colon Cancer Cells Gastroenterology. 134: A-242. DOI: 10.1016/S0016-5085(08)61123-3 |
0.438 |
|
| 2008 |
Natarajan G, Ramalingam S, Sureban SM, May R, Houchen CW, Anant S. 614 RNA Binding Protein RBM3: A Novel Protooncogene Required for Tumor Cells to Overcome G2/M Arrest and Mitotic Catastrophe Gastroenterology. 134. DOI: 10.1016/S0016-5085(08)60404-7 |
0.349 |
|
| Show low-probability matches. |